Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 542,692 shares at $70.61 ($38.1M) on 2020-03-31, disclosed to the SEC on 2020-04-01.
Open-market sale of $38.1M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.00 | 2,800 | $188K | 0.5% |
| 2 | $68.20 | 16,900 | $1.2M | 3.0% |
| 3 | $69.04 | 46,310 | $3.2M | 8.4% |
| 4 | $69.04 | 46,310 | $3.2M | 8.4% |
| 5 | $70.30 | 80,167 | $5.6M | 14.8% |
| 6 | $70.30 | 80,167 |
| $5.6M |
| 14.8% |
| 7 | $70.92 | 31,916 | $2.3M | 5.9% |
| 8 | $70.92 | 31,916 | $2.3M | 5.9% |
| 9 | $70.61 | 78,510 | $5.5M | 14.5% |
| 10 | $70.61 | 78,510 | $5.5M | 14.5% |
| 11 | $71.12 | 24,593 | $1.7M | 4.6% |
| 12 | $71.12 | 24,593 | $1.7M | 4.6% |
| Total | $70.24 avg | 542,692 | $38.1M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |